trial

Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)

NCTId NCT02404155
as of 2026-07-01
at a glance
· Completed
Enrollment 274 (actual)
Primary completion 2021-10-26
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Completed
Enrollment
274 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2015-07
Primary completion
2021-10-26
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Sponsors

Investigators

1
Deanna L. Kelly, Pharm.D., BCPPPrincipal Investigator

Sites

1 total
Catonsville, United States

Facts & assertions

4 sourced
Enrollment
274
Phase
NA
Primary Completion Date
2021-10-26
Status
COMPLETED
relationships
The graph out of here
drug
indication
indication
indication